- Nine Latin American countries including Argentina, Bolivia, Mexico and Venezuela have announced deals to purchase Russia’s Sputnik V COVID-19 vaccine.
- Sputnik V is less expensive and lower maintenance (can be stored in room temperature) than Pfizer’s vaccine, ideal for Latin American economies and climates.
- Argentina has agreed to purchase up to 25M doses and has already distributed 600K since late December.
- Russia’s struggles meeting LatAm demand sparked a local manufacturing agreement with Argentina.
- Despite concerns over Sputnik’s accelerated development, it’s reportedly 91.6% effective.
Russia’s Sputnik V vaccine expands its reach in Latin America
(03/03/2021)